PET imaging has grown over the past two decades to become a
mainstay in the diagnosis and management of cancer patients.
While oncology scans continue to comprise the majority of PET
scans, new radiopharmaceuticals offer the promise of increasing
the efficacy of PET imaging for cardiology and neurology. IMV’s
2022 PET Imaging Market Summary Report monitors trends in PET
scan utilization, the adoption of fixed PET scanners (e.g., PET-only,
PET/CT, and PET/MR), the use of mobile PET services, purchase
plans, and radiopharmaceutical use. Survey results are projected
to the universe of facilities using PET, and the report addresses the
PET unit market for 2022-2026.